KOBAYASHI HEALTHCARE EUROPE LIMITED
Get an alert when KOBAYASHI HEALTHCARE EUROPE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-09-30 (in 1y)
Last filed for 2025-12-31
Confirmation statement due
2027-04-28 (in 11mo)
Last made up 2026-04-14
Watchouts
None on the register
Cash
£9M
+18.2% vs 2024
Net assets
£11M
+7.1% vs 2024
Employees
16
+14.3% vs 2024
Profit before tax
£999K
-25.4% vs 2024
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Turnover | £14,873,980 | £14,325,219 | |
| Operating profit | £1,312,820 | £932,398 | |
| Profit before tax | £1,338,908 | £998,698 | |
| Net profit | £997,599 | £723,616 | |
| Cash | £7,456,809 | £8,814,508 | |
| Total assets less current liabilities | £10,578,817 | £11,164,611 | |
| Net assets | £10,219,362 | £10,942,978 | |
| Equity | £10,219,362 | £10,942,978 | |
| Average employees | 14 | 16 | |
| Wages | £907,586 | £1,032,049 | |
| Directors' remuneration | £393,697 | £274,916 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-12-31 vs 2024-12-31
-
Turnover
-3.7%
£14,873,980 £14,325,219
-
Cash
+18.2%
£7,456,809 £8,814,508
-
Net assets
+7.1%
£10,219,362 £10,942,978
-
Employees
+14.3%
14 16
-
Operating profit
-29%
£1,312,820 £932,398
-
Profit before tax
-25.4%
£1,338,908 £998,698
-
Wages
+13.7%
£907,586 £1,032,049
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating margin | 8.8% | 6.5% | |
| Net margin | 6.7% | 5.1% | |
| Return on capital employed | 12.4% | 8.4% | |
| Gearing (liabilities / total assets) | 31.6% | 35.2% | |
| Current ratio | 3.33x | 2.89x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- KOBAYASHI HEALTHCARE EUROPE LIMITED 2001-04-25 → present
- GUIDEGRAIN LIMITED 2001-03-14 → 2001-04-25
Audit & accounting basis
- Accounting basis
- IFRS
- Auditor
- Blick Rothenberg Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which the directors continue to believe to be appropriate. The company currently holds sufficient cash reserves to maintain its operations and to fund its immediate working capital and capital expenditure requirements from its own internal resources. The directors therefore do not consider the company to be reliant on financial support from group entities. However, the parent company, Kobayashi Pharmaceutical Company Limited, has confirmed that supplemental funding would be made available if required. Accordingly, the directors are satisfied that the company will be able to meet its liabilities as they fall due for the foreseeable future and have prepared the financial statements on a going concern basis.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| AKITA, Koji, Mr. | Director | 2025-03-28 | Sep 1965 | Japanese |
| MORITA, Toyohiro, Mr. | Director | 2024-01-01 | Aug 1976 | Japanese |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FUJIWARA, Masaaki | Secretary | 2013-01-24 | 2018-06-30 |
| MIYANISHI, Kazuhito | Secretary | 2003-04-15 | 2006-03-17 |
| TOYODA, Norikazu | Secretary | 2006-03-17 | 2013-01-24 |
| YAGI, Takaki | Secretary | 2018-06-30 | 2023-04-04 |
| AQUIS SECRETARIES LIMITED | Corporate Secretary | 2001-04-24 | 2003-04-15 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 2001-03-14 | 2001-04-24 |
| FUJIWARA, Masaaki | Director | 2013-01-24 | 2018-06-30 |
| KATSUKI, Kazuyuki | Director | 2001-06-08 | 2006-03-31 |
| MIYANISHI, Kazuhito | Director | 2012-10-01 | 2022-10-27 |
| MIYANISHI, Kazuhito | Director | 2001-04-24 | 2006-03-17 |
| SASAKI, Tsukasa | Director | 2006-04-03 | 2010-10-27 |
| TANAKA, Masaaki, Mr. | Director | 2010-10-27 | 2012-10-01 |
| TOYODA, Norikazu, Mr. | Director | 2023-01-01 | 2025-03-28 |
| TOYODA, Norikazu | Director | 2006-03-17 | 2013-01-24 |
| YAGI, Takaki | Director | 2018-06-30 | 2024-03-29 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 2001-03-14 | 2001-04-24 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Kobayashi Pharmaceutical Co., Ltd | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 119 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-04-22 RESOLUTIONS Resolution
- 2023-04-22 MA Memorandum articles
- 2023-04-17 CC04 Statement of companys objects
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-04-03 | AA | accounts | Accounts with accounts type full | |
| 2025-05-06 | AA | accounts | Accounts with accounts type full | |
| 2025-04-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-04-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-03 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-27 | AA | accounts | Accounts with accounts type full | |
| 2024-01-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-04-22 | RESOLUTIONS | resolution | Resolution | |
| 2023-04-22 | MA | incorporation | Memorandum articles | |
| 2023-04-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-17 | CC04 | change-of-constitution | Statement of companys objects | |
| 2023-04-14 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-02-07 | AA | accounts | Accounts with accounts type full | |
| 2023-01-06 | AP01 | officers | Appoint person director company with name date | |
| 2022-11-03 | TM01 | officers | Termination director company with name termination date | |
| 2022-04-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-01-26 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.